The 1st Tumor CytokinoTherapy Database (TCTD-1)

Launched by ONCOCARECLINIC 308 LTD · Jan 15, 2024

Keywords

ClinConnect Summary

The Tumor CytokinoTherapy Database (TCTD-1) is a clinical trial aimed at understanding how different factors can influence the response of cancer patients to a treatment called cytokinotherapy. This type of therapy is known to be effective and cost-efficient for treating tumors, but researchers want to gather more information to help personalize and improve treatment for patients. By collecting data on various characteristics of patients and their outcomes from this therapy, the study hopes to find patterns that can help predict how well individuals will respond to treatment.

To be eligible for this trial, participants must be adults aged 18 years or older who have been diagnosed with cancer and are receiving or have completed at least one course of cytokinotherapy. However, patients under 18, those over 95, and individuals with specific types of cancers, like blood cancers or thyroid tumors, cannot participate. If you join the trial, you can expect to provide information about your health and treatment, which will help researchers develop better predictive models for managing cancer care. This study is currently recruiting participants, and your involvement could contribute to valuable advancements in cancer treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • adult patients aged 18 years or older with cancer who do not meet exclusion criteria, applied to the OncoCare308 Clinic Ltd. hospital for cytogenetic therapy, and are eligible to complete or have completed at least one course of cytogenetic therapy, as determined by the site.
• Exclusion Criteria:
• • Patients under 18 or over 95 years
• • Patients with hematologic cancer or thyroid tumors
• • Patients with contraindications for cytogenetic therapy
• • Patients who die before the start of therapy or before the first course completeness
• • Patients who do not sign the informed consent to be enrolled under the clinical observation in the hospital